Next-Generation-Sequencing for Non-Invasive Prenatal Testing (NGS-NIPT) in China

  • ID: 3816872
  • Report
  • Region: China
  • 37 Pages
  • Kalorama Information
1 of 3
The Market for Next-Generation-Sequencing Neonatal Testing (NGS-NIPT) in China

Next Generation NIPT Sequencing in China estimates the revenues for non-invasive prenatal testing in this emerging market, and generally analyzes the role of next generation sequencing (NGS) in the country. Estimates in this report include revenues for non-invasive prenatal testing using sequencing in China, projections to 2020, market share. Institutions performing NGS and key equipment manufacturers and service providers are discussed.

This report was created as a cooperative project between Kalorama Information and The Freedonia Group, with staff from Freedonia’s Beijing office completing primary and secondary research.
Note: Product cover images may vary from those shown
2 of 3
Chapter One: Executive Summary
Scope and Methodology
Major Findings of The Report
Chapter Two: Introduction
China in Perspective
Population Trends and Demographics
Aging of Population
Growing Chinese Hospital Sector
Number of Hospitals in China, 2004-2015
Hospitals in China by Class (Class I, Class II, Class III)
Resource Constraints in Hospitals
Intellectual Property Issues
Higher Out of Pocket Spending in China
Percent of Spending Out of Pocket: China vs. Other Nations
Healthcare Reform
Disease Costs
Sequencing Introduction
Next Generation Sequencing
Sequencing in China
Products Approved
Institutions Performing NGS in China
Technologies Used for Newborn Screening
Traditional Tests
Chapter Three: Market Analysis
Relevant Demographics
Hospital Use of NGS
Hospitals Using NGS: Outsourced vs. In-House
Major Competitors
Leading Companies in Next Generation Sequencing in China (Equipment
Providers, Test Makers, Service Providers)
Chinese NGS-NIPT Market
Market Size and Forecast to 2020
Market Share of NGS-NIPT in China and Competitive Analysis
Emerging NGS Applications in China
NGS Competitors in China
Amoy Diagnostics Co., LTD
Berry Genomics Co. Ltd
Beijing Genomics Institute (BGI)
CapitalBio Corporation
Daan Gene Co., Ltd.
Shanghai Kehua Bio-engineering
Zhejiang Dian Diagnostics
Wuxi AppTec Co. LTD.
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown